Curative effect observation of Qingrehuoxuejiedu method treating acute radiodermatitis

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-16009868

Enrollment

Unknown

Registered

2016-11-15

Start date

2016-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute radiodermatitis

Interventions

treatment group:Qingrehuoxuejiedu Chinese medicine topical treatment

control group:Kangfuxin topical treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Tumor patients receiving the initial radiotherpy; 2. Be diagnosed as asacute radiodermatitis for 1-3 levels; 3. Aged 18-75 years; 4. anticipated survival time more than 3 months; 5. The KPS level above 60; 6. Voluntarily take part in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.With the serious heat,lung,liver,kidney or mental diseases; 2.With the serious topical infection; 3.Medicine allergy; 4.Allergic constitution; 5.In another experiment at the same time.

Design outcomes

Primary

Measure	Time frame
Radiothermitis level;	—

Secondary

Measure	Time frame
Erythema level;Pruritus level;	—

Countries

China

Contacts

Public ContactXianwen Wu

Xiyuan Hospital, China Academy of Traditional Chinese Medicine

13520489882@163.com13520489882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026